Quantum-Si CEO Jeff Hawkins to speak at H.C.Wainwright BioConnect Investor Conference

Quantum-Si CEO Jeff Hawkins to speak at H.C.Wainwright BioConnect Investor Conference
Quantum-Si CEO set for conference

Quantum-Si announced that its CEO Jeff Hawkins will participate in a fireside chat during the H.C.Wainwright 4th Annual BioConnect Investor Conference.

The company is offering a live webcast for those interested in following the discussion, as it aims to engage with the investor community and highlight developments in the proteomics sector. Registration for the event remains open, providing access to insights from Quantum-Si leadership as they connect with industry stakeholders.

Quantum-Si recently presented single molecule protein sequencing data at the AACR conference, advancing its methods for post-translational modification analysis during the event. The company also showcased how next-generation protein sequencing is being used to develop new cancer treatment strategies in a live AACR presentation. These initiatives mark ongoing efforts to demonstrate the utility of its proteomics technology to both industry and investors.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.